Current Research Studies

Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-Term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated with Miransertib in Other Studies

ARQ_Extension

  • Condition(s): Other
  • Phase: II
  • Clinicaltrials.gov ID: NCT04980872

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: